Port-Site Metastasis Identified on Prostate-Specific Membrane Antigen-Targeted 18 F-DCFPyL PET/CT After Robot-Assisted Laparoscopic Radical Prostatectomy

Clin Nucl Med. 2023 Apr 1;48(4):e186-e187. doi: 10.1097/RLU.0000000000004544. Epub 2023 Jan 12.

Abstract

Port-site metastasis is an extremely rare complication following minimally invasive oncologic surgery for prostate cancer. We present the case of a 74-year-old man who underwent robot-assisted laparoscopic radical prostatectomy followed by salvage radiotherapy. Despite treatment, he developed biochemical recurrence. However, there was no evidence of disease on CT and bone scan at a prostate-specific antigen of 4.6 ng/mL. Subsequently, 18 F-DCFPyL PET/CT revealed a solitary focus of intense uptake in the right rectus abdominis muscle that was felt to represent a port-site metastasis. Histopathologic evaluation with immunostaining following ultrasound-guided needle biopsy confirmed the presence of metastatic adenocarcinoma of the prostate.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Humans
  • Laparoscopy*
  • Male
  • Positron Emission Tomography Computed Tomography
  • Prostate / pathology
  • Prostate-Specific Antigen
  • Prostatectomy
  • Prostatic Neoplasms* / pathology
  • Robotics*
  • Tomography, X-Ray Computed

Substances

  • Prostate-Specific Antigen